Artificial Intelligence in Colorectal Cancer Histopathology: From Image Analysis to Clinical Translation—A Systematic Review
Abstract
Background: Convolutional neural networks (CNNs) are increasingly applied to haematoxylin and eosin (H&E)-stained colorectal cancer (CRC) histopathology, but it remains unclear how far reported performance reflects readiness for clinical use. Methods: Following PRISMA 2020, PubMed and Scopus were searched to 30 August 2026, and two reviewers independently selected studies; 102 studies were included. Each was classified by principal task, level of analysis, and validation strategy, and risk of bias was assessed with an adapted QUADAS-2 tool. Results: Most studies addressed binary tumour-versus-benign classification (53.9%) or multiclass tissue classification (26.5%); dysplasia grading, segmentation, and molecular prediction were less common. Over half evaluated isolated patches, 62.7% relied on public datasets, and only 21.6% tested a fixed model on an independent external cohort. Only 6 (5.9%) studies were at low risk of bias. Near-perfect accuracies came mainly from randomly partitioned benchmarks, performance declined on independent cohorts, and no study reported a prospective trial. Conclusions: This systematic review provides a task- and validation-stratified appraisal of CNNs in CRC histopathology, showing that the main barrier to clinical adoption is no longer algorithmic accuracy but the quality of validation evidence. Patient-level data separation, multicentre external validation, slide-level evaluation, and prospective evaluation of pathologist–AI collaboration are priorities.